Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 1, 2026, Sapiens International Corporation N.V. (SPNS) has a Wall Street consensus price target of $38.00, based on estimates from 10 covering analysts. With the stock currently trading at $43.45, this represents a potential downside of -12.5%. The company has a market capitalization of $2.43B.
Analyst price targets range from a low of $38.00 to a high of $38.00, representing a 0% spread in expectations. The median target of $38.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 4 analysts rating the stock as a Buy or Strong Buy,5 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, SPNS trades at a trailing P/E of 33.7x and forward P/E of 27.9x. The forward PEG ratio of 1.40 indicates reasonable valuation for growth. Analysts expect EPS to grow +36.8% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $47.16, with bear and bull scenarios of $4.42 and $69.32 respectively. Model confidence stands at 62/100, reflecting moderate uncertainty in projections.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how SPNS stacks up against sector leader NVIDIA Corporation.
Start ComparisonSPNS's consensus price target is $38, -12.5% below the current price of $43.45. The 10 analysts tracking SPNS see downside risk at present valuations.
SPNS has a consensus rating of "Hold" based on 10 Wall Street analysts. The rating breakdown is mixed, with 5 Hold ratings making up the largest segment. The consensus 12-month price target of $38 implies -12.5% downside from current levels.
SPNS trades at a forward P/E of 27.8526x, representing a moderate valuation. With analysts targeting $38 (-12.5% implied move), the stock appears close to fair value.
The most bullish Wall Street analyst has a price target of $38 for SPNS, while the most conservative target is $38. The consensus of $38 represents the median expectation. Our quantitative valuation model projects a bull case target of $69 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
SPNS is moderately covered, with 10 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 5 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month SPNS stock forecast based on 10 Wall Street analysts shows a consensus price target of $38, with estimates ranging from $38 (bear case) to $38 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $47, with bear/bull scenarios of $4/$69.
Our quantitative valuation model calculates SPNS's fair value at $47 (base case), with a bear case of $4 and bull case of $69. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 62/100.
SPNS trades at a forward P/E ratio of 27.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 33.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on SPNS, with 1 Sell ratings and a price target of $38 (-12.5% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
SPNS analyst price targets range from $38 to $38, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $38 consensus represents the middle ground. Our model's $4-$69 range provides an independent fundamental perspective.